Top

Journal of Cancer Research and Clinical Oncology

Published in:

Open Access 01-09-2011 | Original Paper

Expression of cathepsin D and E-cadherin in primary laryngeal cancers correlation with neck lymph node involvement

Authors: Mustafa Paksoy, Umit Hardal, Cakır Caglar

Published in: Journal of Cancer Research and Clinical Oncology | Issue 9/2011

Abstract

Objective

The aim of this study was to investigate the relation between Cathepsin D (Cath-D) and E-Cadherin (E-Cad) expression levels in tumor tissue and neck lymph node metastasis. This attempt should be made to identify new factors that one could be useful in predicting clinical behavior.

Study design

In this study, we investigated rates of dying for E-Cad and Cath-D in paraphin blocks of larynx and neck dissection specimens taken from 56 selected patients. Laryngeal specimens dyed by ECad and Cath-D immunohistochemically. Immunoreactivity classified for E-Cad as positive (75% and above), reduced (25–75%) and negative (below 25%). Immunoreactivity classified for Cath-D:dye absorption rates higher than 50% evaluated positive and absorption rates lower than 50% evaluated negative. We compared the rates of dying for E-Cad and Cath-D groups to with or without neck lymph node metastasis in specimens.

Results

Neck metastasis were found in 41% of patients, in 55.6% of patients, if the E-Cad was negative, 40.6% if it was reduced, 33.3% if it was positive in specimens. The neck metastasis was found in 35.4% of patients with Cath-D expression negative, while 75% of patients was found with Cath-D expression positive.

Conclusion

Neck metastasis was found higher in E-Cad reduced group than positive group. Neck node metastasis was significantly higher in Cath-D positive group than Cath-D negative group. Cath-D and E-Cad essays may useful in identifying neck lymph node involvement. Cath-D expression levels are more in this predictive factor than E-Cad levels for possibility of neck lymph node metastasis in LSCC.

Almadori G, Bussu F, Cadoni G, Galli J, Paludetti G, Maurizi M (2005) Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Review. Eur J Cancer 41(5):683–693

Andersen PE, Shah JP, Cambronero E, Spiro RH (1994) The role of comprehensive neck dissection with preservation of the spinal accessory nerve in the clinically positive neck. Am J Surg 168:499–502

Andrews NA, Jones AS, Helliwell TR, Kinsella AR (1997) Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer 75:1474–1480

Bagutti C, Speight PM, Watt FM (1998) Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol 186(1):8–16

Bowie GL, Caslin AW, Roland NJ, Field JKMA, Jones AS, Kinsella AR (1993) Expression of the cell–cell adhesion molecule E-cadherin in squamous cell carcinoma of the head and neck. Clin Otolaryngol 18:196–201

Bukholm K, Nesland JM, Karesen R, Jacobsen U, Borresen-Dale AL (1998) E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol 185:262–266

Chang HW, Chow V, Lam KY, Wei WI, Yuen A (2002) Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer 94(2):386–392

Cotran RS, Kumar V, Robbins SL (1994) Robbins pathologic basis of disease, 5th edn. WB Saunders, Philadelphia, pp 745–746

Diniz-Freitas M, García-Caballero T, Antúnez-López J, Gándara-Rey JM, García-García A (2006) Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol 42(2):190–200

Goussia A, Ioachim E, Peschos D, Assimakopoulos D, Vougiouklakis T, Skevas A, Agnantis N (1999) Immunohistochemical expression of cathepsin D in laryngeal epithelial lesions: correlation with CD44 expression, p53 and Rb status and proliferation associated indices. Anticancer Res 19(4B):3055–3060

Hahn SS, Spaulding CA, Kim JA, Constable WC (1987) The prognostic significance of lymph node involvement in pyriform sinus and supraglottic cancers. Int J Radiat Oncol Biol Phys 13:1143–1147

Harrison DFN, Thawley SE (1987) Surgical therapy of the larynx. In: Thawley SE, Panje WR (Eds) Comprehensive management of head and neck tumors, vol. II. WB Saunders, Philadelphia, pp 929–959

Isola J, Weitz S, Visakorpi T et al (1993) Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer. J Clin Oncol 11:36–43

Jemal A et al (2004) Cancer statistics. CA Cancer J Clin 54:8

Johnson JT, Myers EN (1991) Cervical lymph node disease in laryngeal cancer. In: Silver CE (ed) Laryngeal cancer. Thieme Medical Publishers, New York, pp 22–26

Kirchner JA, Carter D (2004) Pathology of the larynx. In: Mills SE (ed) Sternberg’s diagnostic surgical pathology, vol. 2, 4th edn. Gopson Papers Ltd, Noida, India, pp 1007–1032

Lazaris A, Lendari I, Kavantzas N, Kandiloros D, Adamopoulos G, Davaris P (2000) Correlation of tumor markers p53, bel-2 and eathepsin-D with elinieopathologie features and disease-free survival in laryngeal squamous cell carcinoma pathology international 50:717–724

Lee SW (1996) H-cadherin, a novel growth inhibitory function and diminished expression in human breast cancer. Nature Med 2:776–782

Leto G, Gebbia N, Rausa L, Tuminello FM (1992) Cathepsin D in the malignant progression of neoplastic diseases (review). Anticancer Res 12(1):235–240

Lim SC, Zhang S, Ishii G et al (2004) Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res 10(1 Pt 1):166–172

Liu M, Lawson G, Delos M, Jamart J, Remacle M (1997) Expression of E-cadherin adhesion molecule in vocal cord carcinomas. Eur Arch Otorhinolaryngol 254:417–421

Maudelonde T, Martinez P, Laffargue F, Pages A, Rochefort H (1990) Cathepsin-D in human endometrium: induction by progesterone and potential value as a tumor marker. J Clin Endocrinol Metab 70(1):115–121

Maurizi M, Almadori G, Cadoni G et al (1996) Cathepsin D concentration in primary laryngeal cancer: correlation with clinico-pathological parameters, EGFR status and prognosis. Int J Cancer 69(2):105–109

Moe K, Wolf GT, Fisher SG, Hong WK (1996) Regional metastasesin patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg 122:644–648

Pera E, Morena A, Galindo L (1986) Prognostic factors in laryngeal carcinoma. A multifactorial study of 416 cases. Cancer 58:928–934

Richard JM, Sancho-Garnier H, Micheau C, Saravane D, Cachin Y (1987) Prognostic factors in cervical lymph node metastasis in upper respiratory and digestive tract carcinomas: study of 1,713 cases during a 15-year period. Laryngoscope 97:97–101

Rodrigo JP, Dominguez F, Alvarez C, Herrero A, Suarez C (2003) Expression of E-cadherin, CD44s, and CD44v6 in laryngeal and pharyngeal carcinomas. Am J Otolaryngol 24(6):384–389

Schantz SP (1994) Head and neck oncology research. Curr Opin Oncol 6:265–271

Schipper JH, Unger A, Jahnke K (1994) E-cadherin as a functional marker of the differentiation and invasiveness of squamous cell carcinoma of the head and neck. Clin Otolaryngol 19:381–384

Shinohara M, Hiraki A, Ikebe T et al (1998) Immunohistochemical study of desmossomes in oral squamous cell carcinoma: correlation with citokeratin and E-cadherin staining, and with tumour behaviour. J Pathol 184(4):369–381

Smid L, Strojan P, Budihna M, Skrk J, Vrhovec I, Zargi M, Kos J (1997) Prognostic value of cathepsins B, D and steffins A and B in laryngeal carcinoma. Eur Arch Otorhinolaryngol 254(1):S150–S153

Spyratos M, Maudelondet F, Brouilletj P, Brunet M et al (1989) Cathepsin D an independent prognostic factor for metastasis of breast cancer. Lancet 8672:1115–1118

Suen JY, Stern SJ (1996) Cancer of the neck. In: Myers EN, Suen JY (eds) Cancer of the head and neck. WB Saunders, Philadelphia, pp 462–484

Takes RP, Baatenburg de Jong RJ, Schuuring E et al (1997) Markers for assesment of nodal metastasis in laryngeal carcinoma. Arch Otol Head Neck Surg 123:412–419

Tanaka N, Odajima T, Ogi K, Ikeda T, Satoh M (2003) Expression of E-cadherin, a-catenin, and b-catenin in the process oflymph node metastasis in oral squamous cell carcinoma. Br J Cancer 89(3):557–563

Tandona K, Clarkg M, Chamnesgs C, Chirgwinj M, Mcguirew L (1990) Cathepsin D and prognosis in breast cancer. New Engl J Med 322:297–302

Vignon F, Capony F, Chambon M, Freiss G, GarciaM, Rochefort H (1982) Autoendocrine erowth stimulation of the Mcf-7@. 7:185–192

Title: Expression of cathepsin D and E-cadherin in primary laryngeal cancers correlation with neck lymph node involvement
Authors: Mustafa Paksoy
Umit Hardal
Cakır Caglar
Publication date: 01-09-2011
Publisher: Springer-Verlag
Published in: Journal of Cancer Research and Clinical Oncology / Issue 9/2011
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-011-1007-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Expression of cathepsin D and E-cadherin in primary laryngeal cancers correlation with neck lymph node involvement

Abstract

Objective

Study design

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objective

Study design

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 9/2011

Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy

Reconstitution and functional analyses of neutrophils and distinct subsets of monocytes after allogeneic stem cell transplantation

Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer

Synergistic interaction between sunitinib and docetaxel is sequence dependent in human non–small lung cancer with EGFR TKIs-resistant mutation

Validation of cofilin-1 as a biomarker in non-small cell lung cancer: application of quantitative method in a retrospective cohort

Endocrine late effects after total body irradiation in patients who received hematopoietic cell transplantation during childhood: a retrospective study from a single institution

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page